A Medsky Topics feed composed of posts covering recent news related to HIV & AIDS Powered by @medsky.network
Feed on Bluesky
bit.ly
Initiation of Oral Pre-exposure Prophylaxis Associated With Changes in Genital Tract T Cell Phenotypes in Women Exposed to HIV
Using high-parameter flow cytometry of cervical biopsies from HIV-exposed women before and while on oral pre-exposure prophylaxis (PrEP), we found an assoc
buy.stripe.com
Graze Social Tip Jar
Donate to the Graze Social team and keep the feeds flowing!
qburgh.com
Doctors can refuse to treat LGBTQ+ patients in several states. These religious exemption laws lead to drops in HIV testing
An increasing number of U.S. states have passed laws that allow health care providers – including doctors, nurses and pharmacists – to refuse to treat patients based on their personal or religious …
www.healio.com
FDA expedites review of new HIV treatment combo
The FDA has accepted Gilead Sciences’ new drug application for a single-tablet, once-daily HIV treatment combination and granted the application priority review, according to the drug-maker. The inves...
youtube.com
The U.S. just made a risky bet on how it fights HIV/AIDS #hiv #hivpolicy #preventhiv #defeathiv
YouTube video by Melody Schreiber
www.genengnews.com
Long-Term SHIV Suppression Using AAV Gene Therapy
Researchers addressed the need for long-term expression of CCR5-specific antibodies to establish protection from HIV using AAV vectors.
pedaids.org
A Pediatric HIV Crisis Hiding in Plain Sight - EGPAF
New PEPFAR data reveal steep declines across pediatric HIV care. Transparent reporting is essential to ensure children are not lost.
xtramagazine.com
Toronto man set to be the first Canadian cured of HIV | Xtra Magazine
The patient received a stem cell transplant for his cancer that acted as a “double cure” because it contained a rare genetic mutation resistant to HIV
www.healio.com
FDA expedites review of new HIV treatment combo
The FDA has accepted Gilead Sciences’ new drug application for a single-tablet, once-daily HIV treatment combination and granted the application priority review, according to the drug-maker.The investigational combination includes two existing Gilead medications: bictegravir (BIC), a guideline-recommended integrase strand transfer inhibitor; and lenacapavir (LEN), a first-in-class capsid
doi.org
Emergency Department Opt‐Out Testing for Hepatitis B: A Two‐Year UK Multicentre Evaluation of Outcomes Across Seven Sites
Background and Aims An estimated 270 000 people in the UK live with hepatitis B infection, the leading global cause of liver cancer. In 2022, opt-out hepatitis B testing was introduced in emergency .....
xtramagazine.com
Why is the federal government still refusing to decriminalize HIV? | Xtra Magazine
Advocates have demanded change for decades. Canada’s government says there’s no path forward for legal reform
www.motherjones.com
The new frontiers of aging
People with conditions like HIV and brain trauma are now living far longer—and revealing gaps in medical science.
Medsky Topics 
